Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Parkinson's Disease

Free Subscription Articles published in Neurochem Res Retrieve available abstracts of 62 articles: HTML format

Single Articles

April 2024
1. PERLIKOWSKA R, Silva J, Alves C, Susano P, et al
   Neuroprotective and Anti-inflammatory Effects of Rubiscolin-6 Analogs with Proline Surrogates in Position 2.
   Neurochem Res. 2024;49:895-918.
   PubMed     Abstract available
   
   
   March 2024
2. ZHAO J, Wang J, Zhao K, Zhang Y, et al
   Protopanaxadiols Eliminate Behavioral Impairments and Mitochondrial Dysfunction in Parkinson's Disease Mice Model.
   Neurochem Res. 2024 Mar 29. doi: 10.1007/s11064-024-04132.
   PubMed     Abstract available
   
   
   
3. KRYL'SKII ED, Razuvaev GA, Popova TN, Oleinik SA, et al
   6-Hydroxy-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline Demonstrates Neuroprotective Properties in Experimental Parkinson's Disease by Enhancing the Antioxidant System, Normalising Chaperone Activity and Suppressing Apoptosis.
   Neurochem Res. 2024 Mar 19. doi: 10.1007/s11064-024-04125.
   PubMed     Abstract available
   
   
   
4. ESTEVES M, Cristovao AC, Vale A, Machado-Pereira M, et al
   MicroRNA-124-3p Modulates Alpha-Synuclein Expression Levels in a Paraquat-Induced in vivo Model for Parkinson's Disease.
   Neurochem Res. 2024 Mar 7. doi: 10.1007/s11064-024-04130.
   PubMed     Abstract available
   
   
   February 2024
5. SHEN J, Chen S, Li X, Wu L, et al
   Salidroside Mediated the Nrf2/GPX4 Pathway to Attenuates Ferroptosis in Parkinson's Disease.
   Neurochem Res. 2024 Feb 29. doi: 10.1007/s11064-024-04116.
   PubMed     Abstract available
   
   
   
6. XU F, Bian N, Li X
   SNHG14 Elevates NFAT5 Expression Through Sequestering miR-375-3p to Promote MPP + -Induced Neuronal Apoptosis, Inflammation, and Oxidative Stress in Parkinson's Disease.
   Neurochem Res. 2024 Feb 21. doi: 10.1007/s11064-024-04106.
   PubMed     Abstract available
   
   
   
7. YANG J, Du C, Li Y, Liu R, et al
   Contrasting Iron Metabolism in Undifferentiated Versus Differentiated MO3.13 Oligodendrocytes via IL-1beta-Induced Iron Regulatory Protein 1.
   Neurochem Res. 2024;49:466-476.
   PubMed     Abstract available
   
   
   January 2024
8. VASUDEVAN SAJINI D, Thaggikuppe Krishnamurthy P, Chakkittukandiyil A, Mudavath RN, et al
   Orientin Modulates Nrf2-ARE, PI3K/Akt, JNK-ERK1/2, and TLR4/NF-kB Pathways to Produce Neuroprotective Benefits in Parkinson's Disease.
   Neurochem Res. 2024 Jan 26. doi: 10.1007/s11064-024-04099.
   PubMed     Abstract available
   
   
   
9. DE ASSIS ALC, de Araujo Rodrigues P, de Morais SM, Rodrigues ALM, et al
   Byrsonima sericea Ethanol Extract Protected PC12 Cells from the Oxidative Stress and Apoptosis Induced by 6-Hydroxydopamine.
   Neurochem Res. 2024;49:234-244.
   PubMed     Abstract available
   
   
   
10. NISHIGUCHI H, Omura T, Sato A, Kitahiro Y, et al
    Luteolin Protects Against 6-Hydoroxydopamine-Induced Cell Death via an Upregulation of HRD1 and SEL1L.
    Neurochem Res. 2024;49:117-128.
    PubMed     Abstract available
    
    
    August 2023
11. HE ZQ, Huan PF, Wang L, He JC, et al
    Compound Dihuang Granule Changes Gut Microbiota of MPTP-Induced Parkinson's Disease Mice via Inhibiting TLR4/NF-kappaB Signaling.
    Neurochem Res. 2023 Aug 10. doi: 10.1007/s11064-023-04004.
    PubMed     Abstract available
    
    
    
12. DA CRUZ GUEDES E, Erustes AG, Leao AHFF, Carneiro CA, et al
    Cannabidiol Recovers Dopaminergic Neuronal Damage Induced by Reserpine or alpha-synuclein in Caenorhabditis elegans.
    Neurochem Res. 2023;48:2390-2405.
    PubMed     Abstract available
    
    
    July 2023
13. TIWARI S, Gupta P, Singh A, Chaturvedi S, et al
    Correction to: 4-Phenylbutyrate Mitigates the Motor Impairment and Dopaminergic Neuronal Death During Parkinson's Disease Pathology via Targeting VDAC1 Mediated Mitochondrial Function and Astrocytes Activation.
    Neurochem Res. 2023 Jul 5. doi: 10.1007/s11064-023-03975.
    PubMed    
    
    
    May 2023
14. SIDDIQUI T, Bhatt LK
    Targeting Sigma-1 Receptor: A Promising Strategy in the Treatment of Parkinson's Disease.
    Neurochem Res. 2023 May 31:1-11. doi: 10.1007/s11064-023-03960.
    PubMed     Abstract available
    
    
    
15. SHARMA M, Sharma N, Khairnar A
    Intranasal Rotenone Induces Alpha-Synuclein Accumulation, Neuroinflammation and Dopaminergic Neurodegeneration in Middle-Aged Mice.
    Neurochem Res. 2023;48:1543-1560.
    PubMed     Abstract available
    
    
    March 2023
16. CHITHRA Y, Dey G, Ghose V, Chandramohan V, et al
    Mitochondrial Complex I Inhibition in Dopaminergic Neurons Causes Altered Protein Profile and Protein Oxidation: Implications for Parkinson's disease.
    Neurochem Res. 2023 Mar 25. doi: 10.1007/s11064-023-03907.
    PubMed     Abstract available
    
    
    
17. MORADI VASTEGANI S, Nasrolahi A, Ghaderi S, Belali R, et al
    Mitochondrial Dysfunction and Parkinson's Disease: Pathogenesis and Therapeutic Strategies.
    Neurochem Res. 2023 Mar 21. doi: 10.1007/s11064-023-03904.
    PubMed     Abstract available
    
    
    February 2023
18. LIU M, Zuo S, Guo X, Peng J, et al
    The Study of Overexpression of Peroxiredoxin-2 Reduces MPP(+)-Induced Toxicity in the Cell Model of Parkinson's Disease.
    Neurochem Res. 2023 Feb 18. doi: 10.1007/s11064-023-03880.
    PubMed     Abstract available
    
    
    
19. NGUYEN HD
    Resveratrol, Endocrine Disrupting Chemicals, Neurodegenerative Diseases and Depression: Genes, Transcription Factors, microRNAs, and Sponges Involved.
    Neurochem Res. 2023;48:604-624.
    PubMed     Abstract available
    
    
    January 2023
20. SHI L, Jia L, Wang Y, Xiu M, et al
    4-Aminopyridine Protects Nigral Dopaminergic Neurons in the MPTP Mouse Model of Parkinson's Disease.
    Neurochem Res. 2023 Jan 5. doi: 10.1007/s11064-022-03845.
    PubMed     Abstract available
    
    
    
21. BROCKMUELLER A, Mahmoudi N, Movaeni AK, Mueller AL, et al
    Stem Cells and Natural Agents in the Management of Neurodegenerative Diseases: A New Approach.
    Neurochem Res. 2023;48:39-53.
    PubMed     Abstract available
    
    
    December 2022
22. LIU Z, Zhuang W, Cai M, Lv E, et al
    Kaemperfol Protects Dopaminergic Neurons by Promoting mTOR-Mediated Autophagy in Parkinson's Disease Models.
    Neurochem Res. 2022 Dec 5. doi: 10.1007/s11064-022-03819.
    PubMed     Abstract available
    
    
    
23. LI YY, Zhou TT, Zhang Y, Chen NH, et al
    Distribution of alpha-Synuclein Aggregation in the Peripheral Tissues.
    Neurochem Res. 2022;47:3627-3634.
    PubMed     Abstract available
    
    
    November 2022
24. ZHOU S, Zhou X, Jiang Z, Ma J, et al
    The Mechanism of SNHG8/Microrna-421-3p/Sorting Nexin 8 Axis on Dopaminergic Neurons in Substantia Nigra in a Mouse Model of Parkinson's Disease.
    Neurochem Res. 2022 Nov 18. doi: 10.1007/s11064-022-03795.
    PubMed     Abstract available
    
    
    October 2022
25. LIN H, Tang R, Fan L, Wang E, et al
    Exogenous Tetranectin Alleviates Pre-formed-fibrils-induced Synucleinopathies in SH-SY5Y Cells by Activating the Plasminogen Activation System.
    Neurochem Res. 2022;47:3192-3201.
    PubMed     Abstract available
    
    
    September 2022
26. DE SIQUEIRA EA, Magalhaes EP, de Assis ALC, Sampaio TL, et al
    1alpha,25-Dihydroxyvitamin D3 (VD3) Shows a Neuroprotective Action Against Rotenone Toxicity on PC12 Cells: An In Vitro Model of Parkinson's Disease.
    Neurochem Res. 2022 Sep 6. pii: 10.1007/s11064-022-03735.
    PubMed     Abstract available
    
    
    August 2022
27. ZHANG W, Liu J, Chen Q, Ding W, et al
    Identification of ADP/ATP Translocase 1 as a Novel Glycoprotein and Its Association with Parkinson's Disease.
    Neurochem Res. 2022 Aug 13. pii: 10.1007/s11064-022-03688.
    PubMed     Abstract available
    
    
    
28. DE ALMEIDA EJR, Ibrahim HJ, Chitolina Schetinger MR, de Andrade CM, et al
    Modulation of Inflammatory Mediators and Microglial Activation Through Physical Exercise in Alzheimer's and Parkinson's Diseases.
    Neurochem Res. 2022 Aug 13. pii: 10.1007/s11064-022-03713.
    PubMed     Abstract available
    
    
    
29. TIWARI S, Gupta P, Singh A, Chaturvedi S, et al
    4-Phenylbutyrate Mitigates the Motor Impairment and Dopaminergic Neuronal Death During Parkinson's Disease Pathology via Targeting VDAC1 Mediated Mitochondrial Function and Astrocytes Activation.
    Neurochem Res. 2022 Aug 3. pii: 10.1007/s11064-022-03691.
    PubMed     Abstract available
    
    
    July 2022
30. FENG H, Xi F
    Miltirone Attenuates Reactive Oxygen Species-Dependent Neuronal Apoptosis in MPP(+)-Induced Cell Model of Parkinson's Disease Through Regulating the PI3K/Akt Pathway.
    Neurochem Res. 2022 Jul 9. pii: 10.1007/s11064-022-03669.
    PubMed     Abstract available
    
    
    
31. KHEZRI MR, Ghasemnejad-Berenji M
    Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease.
    Neurochem Res. 2022 Jul 8. pii: 10.1007/s11064-022-03667.
    PubMed     Abstract available
    
    
    
32. ZAHRA W, Birla H, Singh SS, Rathore AS, et al
    Neuroprotection by Mucuna pruriens in Neurodegenerative Diseases.
    Neurochem Res. 2022;47:1816-1829.
    PubMed     Abstract available
    
    
    June 2022
33. CHEN Y, Li YY, Wang S, Zhou T, et al
    Ginsenoside Rg1 Plays a Neuroprotective Role in Regulating the Iron-Regulated Proteins and Against Lipid Peroxidation in Oligodendrocytes.
    Neurochem Res. 2022;47:1721-1735.
    PubMed     Abstract available
    
    
    
34. TYAGI S, Shekhar N, Thakur AK
    Protective Role of Capsaicin in Neurological Disorders: An Overview.
    Neurochem Res. 2022;47:1513-1531.
    PubMed     Abstract available
    
    
    
35. USTUNDAG FD, Unal I, Ustundag UV, Cansiz D, et al
    3-Pyridinylboronic Acid Ameliorates Rotenone-Induced Oxidative Stress Through Nrf2 Target Genes in Zebrafish Embryos.
    Neurochem Res. 2022;47:1553-1564.
    PubMed     Abstract available
    
    
    May 2022
36. NGUYEN TT, Bao NS, Van Vo G
    Advances in Hydrogel-Based Drug Delivery Systems for Parkinson's Disease.
    Neurochem Res. 2022 May 20. pii: 10.1007/s11064-022-03617.
    PubMed     Abstract available
    
    
    
37. ADEBAYO OG, Aduema W, Emmanuel MU, Ben-Azu B, et al
    The Anti-Parkinson Potential of Gingko biloba-Supplement Mitigates Cortico-Cerebellar Degeneration and Neuropathobiological Alterations via Inflammatory and Apoptotic Mediators in Mice.
    Neurochem Res. 2022 May 9. pii: 10.1007/s11064-022-03600.
    PubMed     Abstract available
    
    
    April 2022
38. NING B, Zhang Q, Wang N, Deng M, et al
    Correction to: beta-Asarone Regulates ER Stress and Autophagy Via Inhibition of the PERK/CHOP/Bcl-2/Beclin-1 Pathway in 6-OHDA-Induced Parkinsonian Rats.
    Neurochem Res. 2022 Apr 18. pii: 10.1007/s11064-022-03601.
    PubMed    
    
    
    February 2022
39. HE L, Wang J, Yang Y, Li J, et al
    Mitochondrial Sirtuins in Parkinson's Disease.
    Neurochem Res. 2022 Feb 26. pii: 10.1007/s11064-022-03560.
    PubMed     Abstract available
    
    
    
40. PEREZ VISNUK D, Teran MDM, Savoy de Giori G, LeBlanc JG, et al
    Neuroprotective Effect of Riboflavin Producing Lactic Acid Bacteria in Parkinsonian Models.
    Neurochem Res. 2022 Feb 3. pii: 10.1007/s11064-021-03520.
    PubMed     Abstract available
    
    
    January 2022
41. MARIN C, Fuentes M, Alobid I, Tubita V, et al
    Olfactory Bulb Excitotoxicity as a Gap-Filling Mechanism Underlying the Link Between Traumatic Brain Injury-Induced Secondary Neuronal Degeneration and Parkinson's Disease-Like Pathology.
    Neurochem Res. 2022 Jan 24. pii: 10.1007/s11064-021-03503.
    PubMed     Abstract available
    
    
    December 2021
42. XU X, Zhang Y, Kang Y, Liu S, et al
    LncRNA MIAT Inhibits MPP(+)-Induced Neuronal Damage Through Regulating the miR-132/SIRT1 Axis in PC12 Cells.
    Neurochem Res. 2021;46:3365-3374.
    PubMed     Abstract available
    
    
    
43. LI X, Su Y, Li N, Zhang FR, et al
    Berberine Attenuates MPP(+)-Induced Neuronal Injury by Regulating LINC00943/miR-142-5p/KPNA4/NF-kappaB Pathway in SK-N-SH Cells.
    Neurochem Res. 2021;46:3286-3300.
    PubMed     Abstract available
    
    
    
44. FAN H, Li Y, Sun M, Xiao W, et al
    Hyperoside Reduces Rotenone-induced Neuronal Injury by Suppressing Autophagy.
    Neurochem Res. 2021;46:3149-3158.
    PubMed     Abstract available
    
    
    October 2021
45. ROE K
    An Alternative Explanation for Alzheimer's Disease and Parkinson's Disease Initiation from Specific Antibiotics, Gut Microbiota Dysbiosis and Neurotoxins.
    Neurochem Res. 2021 Oct 20. pii: 10.1007/s11064-021-03467.
    PubMed     Abstract available
    
    
    
46. MISHRA AK, Dixit A
    Dopaminergic Axons: Key Recitalists in Parkinson's Disease.
    Neurochem Res. 2021 Oct 12. pii: 10.1007/s11064-021-03464.
    PubMed     Abstract available
    
    
    August 2021
47. ZHONG Z, Chen W, Gao H, Che N, et al
    Fecal Microbiota Transplantation Exerts a Protective Role in MPTP-Induced Parkinson's Disease via the TLR4/PI3K/AKT/NF-kappaB Pathway Stimulated by alpha-Synuclein.
    Neurochem Res. 2021 Aug 4. pii: 10.1007/s11064-021-03411.
    PubMed     Abstract available
    
    
    
48. XU F, Wang H, Tian J, Xu H, et al
    Down-Regulation of ID2-AS1 Alleviates the Neuronal Injury Induced by 1-Methy1-4-Phenylpyridinium in Human Neuroblastoma Cell Line SH-SY5Y Cells Through Regulating miR-199a-5p/IFNAR1/JAK2/STAT1 Axis.
    Neurochem Res. 2021;46:2192-2203.
    PubMed     Abstract available
    
    
    July 2021
49. PEREZ-BARRON G, Montes S, Aguirre-Vidal Y, Santiago M, et al
    Antioxidant Effect of Hydroxytyrosol, Hydroxytyrosol Acetate and Nitrohydroxytyrosol in a Rat MPP(+) Model of Parkinson's Disease.
    Neurochem Res. 2021 Jul 14. pii: 10.1007/s11064-021-03379.
    PubMed     Abstract available
    
    
    June 2021
50. LIU X, Wang C, Liu W, Song S, et al
    Oral Administration of Silibinin Ameliorates Cognitive Deficits of Parkinson's Disease Mouse Model by Restoring Mitochondrial Disorders in Hippocampus.
    Neurochem Res. 2021 Jun 7. pii: 10.1007/s11064-021-03363.
    PubMed     Abstract available
    
    
    April 2021
51. WANG X, Liu Z, Wang F
    MicroRNA-93 Blocks Signal Transducers and Activator of Transcription 3 to Reduce Neuronal Damage in Parkinson's Disease.
    Neurochem Res. 2021 Apr 26. pii: 10.1007/s11064-021-03333.
    PubMed     Abstract available
    
    
    
52. RATHORE AS, Birla H, Singh SS, Zahra W, et al
    Epigenetic Modulation in Parkinson's Disease and Potential Treatment Therapies.
    Neurochem Res. 2021 Apr 26. pii: 10.1007/s11064-021-03334.
    PubMed     Abstract available
    
    
    
53. ZHENG Y, Liu J, Zhuang J, Dong X, et al
    Silencing of UCA1 Protects Against MPP(+)-Induced Cytotoxicity in SK-N-SH Cells via Modulating KCTD20 Expression by Sponging miR-423-5p.
    Neurochem Res. 2021;46:878-887.
    PubMed     Abstract available
    
    
    March 2021
54. LIU X, Liu S, Tang Y, Pu Z, et al
    Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Diseas
    Neurochem Res. 2021 Mar 15. pii: 10.1007/s11064-021-03293.
    PubMed     Abstract available
    
    
    
55. ZENG X, An H, Yu F, Wang K, et al
    Benefits of Iron Chelators in the Treatment of Parkinson's Disease.
    Neurochem Res. 2021 Mar 1. pii: 10.1007/s11064-021-03262.
    PubMed     Abstract available
    
    
    February 2021
56. XIN C, Liu J
    Long Non-coding RNAs in Parkinson's Disease.
    Neurochem Res. 2021 Feb 5. pii: 10.1007/s11064-021-03230.
    PubMed     Abstract available
    
    
    January 2021
57. RAJPUT C, Sarkar A, Sachan N, Rawat N, et al
    Is Gut Dysbiosis an Epicenter of Parkinson's Disease?
    Neurochem Res. 2021 Jan 5. pii: 10.1007/s11064-020-03187.
    PubMed     Abstract available
    
    
    
58. LARANJINHA J, Nunes C, Ledo A, Lourenco C, et al
    The Peculiar Facets of Nitric Oxide as a Cellular Messenger: From Disease-Associated Signaling to the Regulation of Brain Bioenergetics and Neurovascular Coupling.
    Neurochem Res. 2021;46:64-76.
    PubMed     Abstract available
    
    
    
59. GONZALEZ A
    Antioxidants and Neuron-Astrocyte Interplay in Brain Physiology: Melatonin, a Neighbor to Rely on.
    Neurochem Res. 2021;46:34-50.
    PubMed     Abstract available
    
    
    November 2020
60. AVCI B, Gunaydin C, Guvenc T, Yavuz CK, et al
    Idebenone Ameliorates Rotenone-Induced Parkinson's Disease in Rats Through Decreasing Lipid Peroxidation.
    Neurochem Res. 2020 Nov 28. pii: 10.1007/s11064-020-03186.
    PubMed     Abstract available
    
    
    
61. LIU T, Zhang Y, Liu W, Zhao J, et al
    LncRNA NEAT1 Regulates the Development of Parkinson's Disease by Targeting AXIN1 Via Sponging miR-212-3p.
    Neurochem Res. 2020 Nov 26. pii: 10.1007/s11064-020-03157.
    PubMed     Abstract available
    
    
    
62. DONG Y, Xiong J, Ji L, Xue X, et al
    MiR-421 Aggravates Neurotoxicity and Promotes Cell Death in Parkinson's Disease Models by Directly Targeting MEF2D.
    Neurochem Res. 2020 Nov 12. pii: 10.1007/s11064-020-03166.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.